Your email has been successfully added to our mailing list.

×
1.30422675433205E-16 1.30422675433205E-16 -0.00146842878120408 -0.00146842878120408 -0.0190895741556533 -0.0146842878120411 -0.0234067547723934 -0.00954478707782665
Stock impact report

BRIEF-AC Immune Says Co Remains On Track To Deliver All Clinical And Preclinical Readouts Expected In 2020 [Reuters]

AC Immune SA (ACIU)  More Company Research Source: Reuters
Last ac immune sa earnings: 11/13 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: acimmune.com/en/investors
PDF BRIEF-AC Immune Says Co Remains On Track To Deliver All Clinical And Preclinical Readouts Expected In 2020 June 26 (Reuters) - AC Immune SA: * AC IMMUNE SA - REMAIN ON TRACK TO DELIVER ALL CLINICAL AND PRECLINICAL READOUTS EXPECTED IN 2020 Source text for Eikon: Further company coverage: [Read more]
Impact snapshot Event time: ACIU
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last price
VWAP
High:
Max up
High:
Low:
Max down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Opt-in for
ACIU alerts
from News Quantified
Opt-in for
ACIU alerts

from News Quantified
Opt-in for
ACIU alerts

from News Quantified